Hinotori
Payments companies reported to CMS as associated with Hinotori. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hinotori, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hinotori
These are the largest totals companies reported as associated with Hinotori. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eduardo Parra Davila | West Palm Beach, FL | Colon & Rectal Surgery | $41,624.54 |
| Antonio Gargiulo | Boston, MA | Reproductive Endocrinology | $32,790.11 |
| John Lenihan | Tacoma, WA | Gynecology | $12,623.08 |
| Farid Gharagozloo | Orlando, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $11,342.72 |
| Mona Orady | San Francisco, CA | Obstetrics & Gynecology | $7,252.87 |
| Camran Nezhat | Palo Alto, CA | Obstetrics & Gynecology | $2,911.92 |
| Kevin Davis | Englewood, CO | Gynecologic Oncology | $2,864.95 |
| Harcharan Gill | Stanford, CA | Urology | $2,536.92 |
| George Chang | Houston, TX | Colon & Rectal Surgery | $1,636.34 |
| Erika Balassiano | Palo Alto, CA | Obstetrics & Gynecology | $1,613.10 |
Prescribed Hinotori?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.